Other studies have suggested that SRARP is also involved in the transcriptional activities of ER and the activation of ER results in the suppression of SRARP expression in ER+ breast cancer cells (Luo and Zhang, 2016; Luo et al., 2016). Here, SRARP is linked to breast cancer.